P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
BY MARK SCHOLZ, MD At the first ever Active Surveillance Convention, a conference I attended back in 2007, many experts openly bemoaned that the word “CANCER” profoundly overstates the significance …
BY MARK SCHOLZ, MD Avodart and Proscar are FDA-approved for treating urinary side effects from prostate enlargement. The generic name for Avodart is dutasteride; the generic name for Proscar is finasteride. These medications, …
BY MARK SCHOLZ, MD After sitting down with a new patient Tom, a charming 80-year-old man who was recently found to have a prostate nodule and a PSA elevated up to 50, …
BY MARK SCHOLZ, MD Prostate cancer is the most common form of cancer in men. While some types of prostate cancer are life-threatening, some types are not. Recent media reports …
BY MARK SCHOLZ, MD Metastases are what makes cancer dangerous. Uncontrolled cell growth disrupts normal organ function. Some organs, like lymph nodes for example, continue to function well, even when the cancer …
BY MARK SCHOLZ, MD It seems we have a national passion for prostate biopsies. A million men are biopsied every year. Two hundred thousand of them will be diagnosed with prostate cancer …
BY MARK SCHOLZ, MD As men get older, they almost all develop enlargement of the prostate. Invariably, PSA rises as a result. PSA comes both from the prostate gland and …
BY MARK SCHOLZ, MD There are two different ways to do a prostate biopsy – targeted and random. The random 12-core prostate biopsy is standard and has been in use for over …
BY MARK SCHOLZ, MD Your PSA is elevated. Now your doctor recommends a needle biopsy, 12 cores through the rectum to check for cancer in the prostate. Sounds icky but also logical …
BY MARK SCHOLZ, MD Over the last 30 years most attempts to harness the immune system to fight cancer have been disappointing. We now know that these therapeutic attempts failed because they …